Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.
Eschbach RS, Clevert DA, Hirner-Eppeneder H, Ingrisch M, Moser M, Schuster J, Tadros D, Schneider M, Kazmierczak PM, Reiser M, Cyran CC. Eschbach RS, et al. PLoS One. 2017 Jan 6;12(1):e0169323. doi: 10.1371/journal.pone.0169323. eCollection 2017. PLoS One. 2017. PMID: 28060884 Free PMC article.
Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
Cyran CC, von Einem JC, Paprottka PM, Schwarz B, Ingrisch M, Dietrich O, Hinkel R, Bruns CJ, Clevert DA, Eschbach R, Reiser MF, Wintersperger BJ, Nikolaou K. Cyran CC, et al. Invest Radiol. 2012 Jan;47(1):49-57. doi: 10.1097/RLI.0b013e3182300fe4. Invest Radiol. 2012. PMID: 21934514
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.
Eschbach RS, Fendler WP, Kazmierczak PM, Hacker M, Rominger A, Carlsen J, Hirner-Eppeneder H, Schuster J, Moser M, Havla L, Schneider MJ, Ingrisch M, Spaeth L, Reiser MF, Nikolaou K, Cyran CC. Eschbach RS, et al. PLoS One. 2015 Feb 10;10(2):e0115543. doi: 10.1371/journal.pone.0115543. eCollection 2015. PLoS One. 2015. PMID: 25668193 Free PMC article.
68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.
Kazmierczak PM, Todica A, Gildehaus FJ, Hirner-Eppeneder H, Brendel M, Eschbach RS, Hellmann M, Nikolaou K, Reiser MF, Wester HJ, Kropf S, Rominger A, Cyran CC. Kazmierczak PM, et al. Among authors: eschbach rs. PLoS One. 2016 Dec 19;11(12):e0168248. doi: 10.1371/journal.pone.0168248. eCollection 2016. PLoS One. 2016. PMID: 27992512 Free PMC article.
18F-FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanoma.
Eschbach RS, Kazmierczak PM, Heimer MM, Todica A, Hirner-Eppeneder H, Schneider MJ, Keinrath G, Solyanik O, Olivier J, Kunz WG, Reiser MF, Bartenstein P, Ricke J, Cyran CC. Eschbach RS, et al. Cancer Imaging. 2018 Jan 18;18(1):2. doi: 10.1186/s40644-018-0135-y. Cancer Imaging. 2018. PMID: 29347968 Free PMC article.
14 results